Search   Advanced Search
LATEST NEWS
 
 
News
 Latest Headlines
 Quick Facts
 Breaking News
 Top Stories
 Feature Articles
 Politics
 US Policy
 General
 Commodities
 Canadian
 UK
 Indian
 Wallstreet Events
Industry News
Economics
 US Economic News
 European Economic News
 Asian Economic News
 All Economic News
Forex
 FX Top Stories
 Currency Alerts
 Mkt Sensitive News
 Politics
 European Mkt Updates
 Asian Mkt Updates
 Treasury Mkt Updates
Entertainment
 Pop
 Rock
 Classic Rock
 Rap/Hip-Hop
 Country
 Alternative
 Oldies
 Movie Reviews
 DVD Releases
 Box Office
 Slide Shows
 Business News
Press Releases
Commentary/Analysis
 Daily Market Analysis
 US Market Updates
 US Commentary
 Asian Commentary
 European Commentary
 Canadian Commentary
 Indian Commentary
 Sector/Market Trends
Stock Alerts
 Stocks To Watch
 Long Term Stocks
 Before the Bell
 $5 and Under
 After the Bell
 Intraday Updates
 IPOs
 Hot Stocks
Earnings Calendars
 Upcoming Earnings
 Latest Earnings
 Pos Pre Announcements
 Neg Pre Announcements
Corporate Calendars
 Stock Splits
 Stock Buybacks
 Dividends
 Conference Calls
 FDA Calendar
 Board Meetings
 Mergers & Acquisitions
Ratings Changes
 Upgrades
 Downgrades
 Coverage Initiations
 Coverage Reiterated
Video News
 All Videos
 Market Commentary
 Top Stories
 Economic News
 Political News
 Foreign Markets
 Corporate News
 Entertainment News
Audio News
 Top Stories
 Earnings
 Mergers & Acquisitions
 Market Commentary
 Economic News
 IPOs and New Issues
 Corporate News
 Forex News
 Interviews
 Private Equity
 Economic Calendar
RTT DeskAlert
Font Down Font Up
Human Genome Sciences Closed Tuesday At Second Consecutive New High For Year
11/4/2009 8:31 AM ET


RELATED NEWS
Human Genome Sciences Receives Complete Response Letter From FDA For Raxibacumab - Update
Human Genome Receives Complete Response Letter From FDA Relating To Raxibacumab Biologics License Application - Quick Facts
Human Genome Sciences Set New High For Year Monday
Human Genome Sciences Has Jumped To A New High On Study Results
Human Genome Sciences Says BENLYSTA Met Primary Endpoint In BLISS-76 - Quick Facts
(RTTNews) - Human Genome Sciences (HGSI: News ) traded to the upside for the majority of Tuesday's session, but was range-bound during the final 2 hours of the afternoon. The stock closed higher by $2.79 at $28.07 on above average volume.

Human Genome Sciences and GlaxoSmithKline PLC (GSK) announced Monday morning that BENLYSTA met the primary endpoint in the second of two Phase 3 trials in seropositive patients with systemic lupus erythematosus. Human Genome Sciences closed Tuesday at its second consecutive new high for the year.

Click here to receive FREE breaking news email alerts for Human Genome Sciences Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: contact editorial@rttnews.com


Share Article:   Del.icio.us    Digg    Y! My Web    Facebook    My Space

Email        Print        

Comment On This Story
      
Top Stories
Wall Street Closes Lower For The Day, Mixed For The Week

Senate Democrats Fault GOP For Failing To Advance Alternative Health Reforms

New Guidelines Recommend Women Wait Until 21 For Cervical Cancer Screening

"New Moon" Takes Center Stage, Should Post Big Opening Weekend

Valero Energy To Permanently Shutter Delaware City Refinery - Update

Earnings
Escalon Medical Q1 Loss Widens - Quick Facts

Cordy Oilfield Services Q3 Net Loss Narrows - Quick Facts

Triton Energy Slips To Q3 Loss - Quick Facts

Electronic Game Card Revises Q3 Results - Quick Facts

Schneider Power Swings To Profit In Q3 - Quick Facts

US Market Commentary
Bay Street Stocks Slip Slightly Again - Canadian Commentary

Stocks Close Mostly Lower Amid Disappointing Quarterly Results - U.S. Commentary

Stocks Remain Stuck In The Red In Mid-Afternoon Trading - U.S Commentary

Stocks Posting Moderate Losses In Early Afternoon Trading - U.S. Commentary

Stocks Seeing Further Downside In Late Morning Trading - U.S. Commentary

US Economic News
Fed's Fisher: "Too-Big-To-Fail" Must Be Addressed

Philly Fed Index Shows Much Bigger Than Expected Increase In November

Leading Indicators Index Increases For Seventh Straight Month In October

Philly Fed Index Jumps To 16.7 In November

Leading Indicators Index Rose 0.3% In October

Political News
Christian Leaders Unveil "Call To Faith" On Life, Marriage, Religious Freedom

Senate Ethics Committee Admonishes Burris But Finds No Legal Wrongdoing

Senate Democrats Fault GOP For Failing To Advance Alternative Health Reforms

Sen. Nelson Says He Will Vote To Proceed With Debate On Health Care Bill

Sen. Gregg Calls Ron Paul's Fed Audit Amendment "Political Pandering"




 
Markets End Week In Red
11/20/09 04:51
Partisan Debate Precedes Health Reform Vote
11/20/09 03:23
Wall Street Extends Losses
11/20/09 02:13
 

Today's Stocks to Watch
SVN - 7 Days Group Holdings Ltd.
SLW - Silver Wheaton Corp.
CPQQ.OB - China Power Equipment
LIMS - STARLIMS TECHNOLOGY
SPRD - Spreadtrum Communications Inc.
HEAT - SmartHeat Inc

Profit Taking Likely To Contribute To Continued Weakness – RTTNews Daily Market Analysis
The major index futures are currently indicating a notably lower open for stocks on Friday, with the markets likely to see some further downside after closing lower in each of the two previous sessions. With no major economic data on tap for the day, traders have looked to corporate news, including disappointing quarterly results from Dell (DELL). Traders may also continue to cash in on the recent strength in the markets that lifted the major averages to their best closing levels in over a year earlier in the week.

EDITOR'S PICKS
Stocks Close Mostly Lower Amid Disappointing Quarterly Results - U.S. Commentary
Senate Democrats Fault GOP For Failing To Advance Alternative Health Reforms
New Guidelines Recommend Women Wait Until 21 For Cervical Cancer Screening
House Passes Bill To Stop Reduction In Medicare Payments To Doctors
Intuit Posts Wider Loss In Q1, Guides Q2, Backs FY10 Forecast
Gap Q3 Profit Rises 25%; To Buyback $500 Mln Shares
Nokia To Cut Up To 330 Jobs In R&D - Update
Dell Q3 Profit Drops 54%
Belgian Prime Minister Herman Van Rompuy Named First EU President
Fed's Fisher: "Too-Big-To-Fail" Must Be Addressed

MOST READ
Silver Wheaton Shines - Stocks To Watch
Ron Paul's Fed Audit Proposal Passes Financial Services Committee
Sen. Gregg Calls Ron Paul's Fed Audit Amendment "Political Pandering"
Centerpoint Energy Unit Signs Joint Development Deal With FPL Affiliate To Explore Construction Of New Pipeline
Belgian Prime Minister Herman Van Rompuy Named First EU President
MasterCard Inc. Is Picking Up Volume
Berkshire Hathaway Secures $8 Bln. For Burlington Northern Deal - Update
OECD Raises 2010 GDP Growth Outlook; Sees China Leading Global Recovery
Leading Indicators Index Increases For Seventh Straight Month In October
Pakistan-based Terror Groups Plotting More Attacks: India

MOST E-MAILED
Pakistan-based Terror Groups Plotting More Attacks: India
House Passes Bill To Stop Reduction In Medicare Payments To Doctors
AstraZeneca Files NDA For Antiplatelet Treatment Brilinta - Update
Tyson Foods Promotes Donnie Smith To President, CEO - Update
Riots Erupt In Cairo After Egypt's World Cup Football Defeat
CA Inc. Completes Acquisition Of NetQoS - Quick Facts
CA And Salesforce.com Partner To Deliver Agile Development Management In Cloud On Force.com Platform - Quick Facts
Nortel To Delay Auction For Sale Of Its GSM/GSM-R Business - Quick Facts
Novavax To Offer Common Shares In Underwritten Public Offering - Quick Facts
Microvision Prices Public Offering - Quick Facts

SLIDE SHOW: Pittsburgh Plays Host To Third G-20 Summit World leaders met at the G-20 summit in Pittsburgh, where they promised to maintain economic stimulus agreed to in London in April.
  Trading Center

 
Copyright © 2009 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service.

Feedback| Terms of Service | How To Use RTTNews.com| Advertise| Buy Content | RSS